vimarsana.com

Latest Breaking News On - Categoryi innovative drug - Page 1 : vimarsana.com

Dizal s Sunvozertinib Pivotal Study Results Published in The Lancet Respiratory Medicine

/PRNewswire/ Dizal today announced that the results of a phase 2 pivotal study of sunvozertinib for the treatment of platinum-pretreated non-small-cell lung.

Mengzhao wangXiaolin zhangPrnewswire dizalDepartment of pulmonary medicineNational medical products administrationBusiness developmentDepartment of thoracic oncologyLancet respiratory medicineThoracic oncologyCancer hospitalChinese academyPulmonary medicineLung cancer centerPeking union medical college hospitalCategoryi innovative drugIndependent review committee

Dizal s Sunvozertinib Approved by China NMPA with Potential for Best-in-class Therapy in NSCLC with EGFR Exon20ins Mutations

/PRNewswire/ Dizal today announced that sunvozertinib has been approved by the National Medical Products Administration (NMPA) of China for the treatment of.

United statesXiaolin zhangMengzhao wangPrnewswire dizalBusiness developmentNational medical products administrationUnion medical college hospitalAmerican society of clinical oncologyChinese innovativeCategoryi innovative drugClinical oncologyPeking union medical college hospitalIndependent review committeeCancer discoveryDizal pharmaceutical

vimarsana © 2020. All Rights Reserved.